Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORAL-28Standard

NOR-QD

NORETHINDRONE

Standard Dose
0.35MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NOR-QD is listed in Drugs@FDA under application 017060 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NORETHINDRONE Form and strength TABLET;ORAL-28 - 0.35MG Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2015-12-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview NOR-QD is listed in Drugs@FDA under application 017060 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NORETHINDRONE Form and strength TABLET;ORAL-28 - 0.35MG Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2015-12-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
NOR-QD (NORETHINDRONE) | Drug Monograph | MedicHelpline